BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26523102)

  • 21. Inflammatory bowel disease and airway diseases.
    Vutcovici M; Brassard P; Bitton A
    World J Gastroenterol; 2016 Sep; 22(34):7735-41. PubMed ID: 27678355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Who and how to screen for cancer in at-risk inflammatory bowel disease patients.
    Parian A; Lazarev M
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):731-46. PubMed ID: 25592672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of increased subclinical atherosclerosis risk with carotid intima-media thickness and pulse wave velocity in inflamatory bowel disease.
    Alkan E; Karakaş MS; Yıldırım B
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():20-5. PubMed ID: 25910306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arterial stiffness and pulse pressure in CKD and ESRD.
    Briet M; Boutouyrie P; Laurent S; London GM
    Kidney Int; 2012 Aug; 82(4):388-400. PubMed ID: 22534962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cogan's Syndrome in Patients With Inflammatory Bowel Disease--A Case Series.
    Vavricka SR; Greuter T; Scharl M; Mantzaris G; Shitrit AB; Filip R; Karmiris K; Thoeringer CK; Boldys H; Wewer AV; Yanai H; Flores C; Schmidt C; Kariv R; Rogler G; Rahier JF;
    J Crohns Colitis; 2015 Oct; 9(10):886-90. PubMed ID: 26188351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region.
    Muro M; López-Hernández R; Mrowiec A
    World J Gastroenterol; 2014 Nov; 20(41):15037-48. PubMed ID: 25386052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly: the Hoorn Study.
    van Bussel BC; Henry RM; Schalkwijk CG; Dekker JM; Nijpels G; Stehouwer CD
    J Hypertens; 2012 Apr; 30(4):744-52. PubMed ID: 22343535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
    Karmiris K; Bossuyt P; Sorrentino D; Moreels T; Scarcelli A; Legido J; Dotan I; Naismith GD; Jussila A; Preiss JC; Kruis W; Li AC; Bouguen G; Yanai H; Steinwurz F; Katsanos KH; Subramaniam K; Tarabar D; Zaganas IV; Ben-Horin S;
    J Crohns Colitis; 2015 May; 9(5):382-9. PubMed ID: 25740813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications and surgery in the inflammatory bowel diseases biological era.
    Sokol H; Seksik P; Cosnes J
    Curr Opin Gastroenterol; 2014 Jul; 30(4):378-84. PubMed ID: 24840000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory bowel diseases increase future ischemic stroke risk: a Taiwanese population-based retrospective cohort study.
    Huang WS; Tseng CH; Chen PC; Tsai CH; Lin CL; Sung FC; Kao CH
    Eur J Intern Med; 2014 Jul; 25(6):561-5. PubMed ID: 24906568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of endothelial dysfunction in patients with inflammatory bowel disease.
    Roifman I; Sun YC; Fedwick JP; Panaccione R; Buret AG; Liu H; Rostom A; Anderson TJ; Beck PL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):175-82. PubMed ID: 19121648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early atherosclerosis in patients with inflammatory bowel disease.
    Papa A; Danese S; Urgesi R; Grillo A; Guglielmo S; Roberto I; Bonizzi M; Guidi L; De Vitis I; Santoliquido A; Fedeli G; Gasbarrini G; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2006; 10(1):7-11. PubMed ID: 16494104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001.
    Masala G; Bagnoli S; Ceroti M; Saieva C; Trallori G; Zanna I; D'Albasio G; Palli D
    Gut; 2004 Sep; 53(9):1309-13. PubMed ID: 15306591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ankylosing spondylitis and bowel disease.
    Rudwaleit M; Baeten D
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):451-71. PubMed ID: 16777576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiology of inflammatory bowel disease.
    Burisch J; Munkholm P
    Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk.
    Wang X; Keith JC; Struthers AD; Feuerstein GZ
    Cardiovasc Ther; 2008; 26(3):214-23. PubMed ID: 18786091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms.
    Xiao Y; Powell DW; Liu X; Li Q
    Am J Physiol Regul Integr Comp Physiol; 2023 Aug; 325(2):R193-R211. PubMed ID: 37335014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arterial compliance (stiffness) as a marker of subclinical atherosclerosis].
    Nürnberger J; Kribben A; Philipp T; Erbel R
    Herz; 2007 Aug; 32(5):379-86. PubMed ID: 17687527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aging and arterial stiffness.
    Lee HY; Oh BH
    Circ J; 2010 Nov; 74(11):2257-62. PubMed ID: 20962429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.